BLGOOTCChemicals & Allied ProductsFiscal year ends December 31
BIOLARGO, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.07+0.00 (+0.90%)
Close on Oct 19, 2026
- Market cap
- $23.27M
- P/E (TTM)
- –
- Dividend yield
- –
BIOLARGO, INC. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Odor-No-More [Member] | $5.91M | $15.60M | $11.44M | $4.37M | $1.42M | $1.57M | $1.46M | $1.12M | $500.00K | 76.0% | -62.1% |
| BioLargo Engineering, Science & Technologies, LLC [Member] | $2.55M | $3.20M | $2.40M | $1.94M | $1.64M | $1.05M | $999.00K | $863.00K | $12.00K | 32.8% | -20.4% |
| BioLargo Canada [Member] | $86.00K | $72.00K | $30.00K | $1.00K | – | – | – | – | – | 1.1% | +19.4% |
| Clyra Segment [Member] | $0 | $0 | $20.00K | $56.00K | $139.00K | $240.00K | – | – | – | 0.0% | – |
| BioLargo Water [Member] | – | – | – | $1.00K | $12.00K | $37.00K | – | – | – | – | – |
| BioLargo/Other [Member] | – | – | – | – | – | – | – | – | $12.23K | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| BEST [Member] | -$276.00K | -$273.00K | $0 | – | – | – | – | – | – | +1.1% |
| BioLargo Canada [Member] | -$534.00K | -$532.00K | -$695.00K | -$714.00K | – | – | – | – | – | +0.4% |
| BioLargo Energy Technologies, Inc (BETI) [Member] | -$639.00K | -$642.00K | -$1.18M | $0 | – | – | – | – | – | -0.5% |
| BioLargo Engineering, Science & Technologies, LLC [Member] | -$1.09M | -$1.45M | -$1.62M | -$452.00K | -$629.00K | -$619.00K | -$749.00K | -$125.00K | – | -24.9% |
| Odor-No-More [Member] | -$2.32M | $5.92M | $4.34M | $1.13M | -$511.00K | -$493.00K | -$335.00K | -$433.00K | – | -139.1% |
| Clyra Segment [Member] | -$6.07M | -$3.32M | -$2.10M | -$1.38M | $666.00K | -$1.83M | -$1.23M | $868.00K | – | +82.5% |
| BioLargo Water [Member] | – | – | – | -$714.00K | -$616.00K | -$697.00K | -$728.00K | -$801.00K | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $5.77M | $16.76M | $11.46M | $4.43M | $1.57M | $1.83M | $1.46M | $1.12M | $504.00K | 74.3% | -65.6% |
| Service [Member] | $2.00M | $1.02M | $770.00K | $1.45M | $959.00K | $607.00K | $401.00K | $241.00K | $12.00K | 25.7% | +96.5% |
By region
From the segment and revenue-disaggregation notes of Biolargo's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.